Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
Is a |
hepatitis B-virus-vaccine |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
vaccine mod hepatitis B-virus |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
Has manufactured dose form |
Suspension for injection |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
hepatitis B-vaccine 40 µg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
vaccine mod hepatitis B-virus |
false |
Inferred relationship |
Some |
1 |
|